Entero Therapeutics, Inc. (ENTO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 2.6M | 87.7M | 83.32M | 83.46M | 83.48M | 83.84M | 84.39M | 7.49M | 4.96M | 3.98M | 2.35M | 3.53M |
| Cash & Short-Term Investments | 899.78K | 2.52M | 4.47K | 59.35K | 163.48K | 366.79K | 662.48K | 3.43M | 3.71M | 3.29M | 1.24M | 2.06M |
| Cash Only | 899.78K | 2.52M | 4.47K | 59.35K | 163.48K | 366.79K | 662.48K | 3.43M | 3.71M | 3.29M | 1.24M | 2.06M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.31M | 37.49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20K |
| Days Sales Outstanding | 1.71K | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 387.04K | 84.69M | 83.17M | 83.17M | 83.17M | 83.17M | 83.17M | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 45.96M | 47.67M | 1.74M | 1.74M | 1.93M | 1.98M | 1.9M | 83.64M | 1.93M | 1.95M | 1.97M | 2M |
| Property, Plant & Equipment | 0 | 27.52K | 0 | 0 | 126.75K | 144.41K | 163.07K | 207.17K | 210K | 233.72K | 257.13K | 280.25K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 24.12M | 25.8M | 1.68M | 1.68M | 1.68M | 1.68M | 1.68M | 20.04M | 1.68M | 1.68M | 1.68M | 1.68M |
| Intangible Assets | 0 | 21.8M | 0 | 0 | 0 | 0 | 0 | 365.49K | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 7K | 7K | 21.52K | 21.52K | 21.52K | 21.52K | 21.52K | 21.52K | 21.52K | 21.52K |
| Other Non-Current Assets | 21.84M | 49.12K | 49.12K | 49.12K | 98.25K | 128.25K | 31.75K | 63.01M | 11.25K | 11.25K | 11.25K | 18.15K |
| Total Assets | 48.55M | 135.37M | 85.06M | 85.2M | 85.41M | 85.82M | 86.29M | 91.13M | 6.88M | 5.93M | 4.33M | 5.53M |
| Asset Turnover | 0.00x | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -43.15% | 57.74% | -1.42% | -6.51% | 1140.84% | 1347.89% | 1893.76% | 1546.81% | 26.54% | 27.59% | 10.2% | -37.3% |
| Total Current Liabilities | 15.16M | 33.52M | 29.68M | 28.74M | 27.55M | 15.69M | 15.38M | 6.17M | 3.13M | 2.48M | 3.26M | 2.62M |
| Accounts Payable | 3.38M | 4.97M | 3.3M | 2.85M | 2.96M | 2.21M | 2.01M | 2M | 554.28K | 579.29K | 1.59M | 469.76K |
| Days Payables Outstanding | - | - | - | - | - | - | 5.13K | 9.44K | 7.12K | 4.26K | 4.06K | 2.34K |
| Short-Term Debt | 2.16M | 835.61K | 835.61K | 835.61K | 81.51K | 79.45K | 255K | 457.99K | 679.89K | 65.32K | 217.04K | 448.33K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 13M | 27.71M | 25.54M | 25.05M | 24.51M | 13.39M | 13.1M | 3.66M | 1.4M | 1.83M | 1.45M | 1.71M |
| Current Ratio | 0.17x | 2.62x | 2.81x | 2.90x | 3.03x | 5.34x | 5.49x | 1.21x | 1.58x | 1.60x | 0.72x | 1.34x |
| Quick Ratio | 0.17x | 2.62x | 2.81x | 2.90x | 3.03x | 5.34x | 5.49x | 1.21x | 1.58x | 1.60x | 0.72x | 1.34x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 4.56M | 12.29M | 0 | 0 | 59.02K | 80.21K | 101.03K | 7.1M | 146.95K | 165.97K | 184.66K | 196.52K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.4M | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 59.02K | 80.21K | 101.03K | 127.59K | 146.95K | 165.97K | 184.66K | 196.52K |
| Deferred Tax Liabilities | 4.56M | 0 | 0 | 0 | 0 | 0 | 0 | 571.22K | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 12.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 19.72M | 45.81M | 29.68M | 28.74M | 27.61M | 15.77M | 15.49M | 13.27M | 3.28M | 2.65M | 3.45M | 2.82M |
| Total Debt | 2.16M | 835.61K | 835.61K | 835.61K | 140.53K | 159.67K | 356.03K | 6.98M | 826.84K | 231.29K | 401.7K | 644.85K |
| Net Debt | 1.26M | -1.68M | 831.13K | 776.26K | -22.94K | -207.12K | -306.45K | 3.55M | -2.88M | -3.06M | -834.35K | -1.42M |
| Debt / Equity | 0.07x | 0.01x | 0.02x | 0.01x | 0.00x | 0.00x | 0.01x | 0.09x | 0.23x | 0.07x | 0.46x | 0.24x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -11.70x | -25.92x | -17.71x | -51.96x | - | - | - | -139.36x | -580.86x | -2746.33x | -808.08x | -451.95x |
| Total Equity | 30.07M | 89.56M | 55.38M | 56.46M | 57.8M | 70.05M | 70.8M | 77.86M | 3.6M | 3.28M | 881.96K | 2.71M |
| Equity Growth % | -47.98% | 27.85% | -21.78% | -27.48% | 1504.37% | 2036.45% | 7927.77% | 2770.46% | 31.39% | 243.8% | 106.22% | 129.36% |
| Book Value per Share | 18.60 | 54.19 | 11.62 | 11.85 | 12.16 | 15.39 | 30.86 | 59.20 | 10.08 | 8.67 | 7.77 | 23.79 |
| Total Shareholders' Equity | 24.94M | 84.28M | 55.38M | 56.46M | 57.8M | 70.05M | 70.8M | 77.86M | 3.6M | 3.28M | 881.96K | 2.71M |
| Common Stock | 422 | 255 | 477 | 477 | 475 | 474 | 294 | 203 | 156 | 1.35K | 421 | 155 |
| Retained Earnings | -208.78M | -205.8M | -204.65M | -203.65M | -202.39M | -190.15M | -187.57M | -178.76M | -184.33M | -180.23M | -176.79M | -172.6M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 5.13M | 5.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |